Wednesday, July 8, 2026

pharma · Uveal Melanoma · HLA-A2 negative metastatic uveal melanoma · IDYA

IDEAYA Biosciences

News and analysis for IDEAYA Biosciences on NovaPharmaNews — regulatory, clinical, and market coverage.

5000 Shoreline Ct, Suite 300, South San Francisco, California 94080, US HQ
2015 Founded
248 Employees
Public company Type
IDYA · NYSE Ticker
Company details
Status
Public
HQ
5000 Shoreline Ct, Suite 300, South San Francisco, California 94080, US
Founded
2015
Employees
248
Programs
14
Drugs
12
Patents
12
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning IDEAYA Biosciences — regulatory, clinical, and market coverage.

News and analysis for IDEAYA Biosciences on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning IDEAYA Biosciences yet.

Back to company overview →